Clinical trial
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With…
NCT00425932 · Gaylis, Norman B., M.D., Other · Completed
Key facts
| NCT number | NCT00425932 |
|---|---|
| Title | Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis |
| Official title | Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis |
| Lead sponsor | Gaylis, Norman B., M.D., Other |
| Collaborators | Oklahoma Medical Research Foundation Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological |
| Interventions | Rituximab |
| Enrollment | 60 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2012 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: